文献速递创伤与烧伤复苏、休克与脓毒症

纤溶酶血栓弹力图快速识别需大量输血、死亡和高纤溶风险的创伤患者:解决氨甲环酸国际争议的诊断工具?

Plasmin thrombelastography rapidly identifies trauma patients at risk for massive transfusion, mortality, and hyperfibrinolysis: A diagnostic tool to resolve an international debate on tranexamic acid?
PubMed 文献 · J Trauma Acute Care Surg · 2020-01-01
一句话结论P-TEG可在5分钟内分层创伤患者大量输血、死亡和高纤溶风险,联合tPA TEG预测大量输血优于rTEG LY30。

该诊断性研究纳入148例创伤患者,比较无添加剂TEG、外源性纤溶酶TEG(P-TEG)和外源性tPA TEG。P-TEG在4.7±2.5-9.1分钟内出结果,比rTEG LY30快约11倍。P-TEG阳性患者大量输血率30% vs 7%(p=0.0015)、24小时死亡率33.3% vs 7.8%(p=0.0177)、30天死亡率35% vs 16.4%(p=0.0483)均显著更高。P-TEG联合tPA TEG达峰时间预测大量输血的AUC为0.811,优于rTEG LY30的0.708。快速P-TEG结果可能有助于选择性氨甲环酸给药以最大化其时间依赖性疗效。

要点

  • P-TEG阳性定义:P-TEG R时间≥ native TEG R时间;阴性定义为P-TEG R时间< native TEG R时间。
  • P-TEG阳性患者大量输血率30% vs 7%(p=0.0015),24小时死亡率33.3% vs 7.8%(p=0.0177)。
  • P-TEG出结果时间4.7±2.5-9.1分钟,比rTEG LY30(54.2±51.1-58.1分钟)快约11倍(p<0.001)。
  • P-TEG联合tPA TEG达峰时间预测大量输血AUC 0.811,优于rTEG LY30的0.708。
  • P-TEG对纤溶抑制剂耗竭(DFI)预测的阳性预测值58%、阴性预测值81%。

适用人群与场景

  • 创伤患者(N=148),来自急诊/创伤中心,具体纳入排除标准原文未详细提及。

诊断标准与关键阈值

  • P-TEG阳性:P-TEG R时间≥ native TEG R时间;P-TEG阴性:P-TEG R时间< native TEG R时间。
  • P-TEG所用纤溶酶剂量不引起健康对照LY30改变,但导致R时间较native TEG缩短。
  • 高纤溶判定:rTEG LY30阈值7.6%时P-TEG与之相关(p=0.04),阈值3%时无显著相关(p=0.40)。

处置流程与药物剂量

  • 原文未提及具体氨甲环酸剂量、给药途径或疗程;仅提出P-TEG快速结果可能有助于选择性TXA给药以最大化时间依赖性疗效。

红旗征与不能漏的情况

  • P-TEG阳性提示大量输血风险(30% vs 7%)、24小时死亡风险(33.3% vs 7.8%)和30天死亡风险(35% vs 16.4%)显著增高,需立即评估与干预。
  • P-TEG阳性与纤溶抑制剂耗竭(DFI)相关(55% vs 18%,p<0.001),提示高纤溶风险。

研究设计与关键结果

  • 诊断性研究,单中心?原文未提及中心数;样本量N=148创伤患者。
  • 干预/对照:比较无添加剂TEG(rapid/native)、外源性纤溶酶TEG(P-TEG)和外源性tPA TEG三种检测方法。
  • 主要终点:P-TEG预测大量输血AUC 0.686(p=0.028);P-TEG阳性大量输血率30% vs 7%(p=0.0015)。
  • 关键次要终点:24小时死亡率33.3% vs 7.8%(p=0.0177);30天死亡率35% vs 16.4%(p=0.0483);DFI 55% vs 18%(p<0.001);D-二聚体19.9 vs 3.3 μg/mL(p=0.14,趋势)。
  • P-TEG联合tPA TEG达峰时间预测大量输血AUC 0.811 vs rTEG LY30 0.708;出结果时间12.7 vs 54.1分钟。
  • 不良事件:原文未提及。

证据类型、等级与局限

  • 证据类型:诊断性试验研究;证据等级:level V(原文标注)。

对床旁实践的改变

  • P-TEG可在约5分钟内(4.7±2.5-9.1分钟)提供结果,比rTEG LY30快约11倍,可能适用于需要快速决策是否大量输血的创伤患者。
  • P-TEG联合tPA TEG达峰时间预测大量输血优于rTEG LY30(AUC 0.811 vs 0.708),且出结果更快(12.7 vs 54.1分钟)。
  • 对采用选择性氨甲环酸给药的机构,P-TEG快速结果可能有助于在时间窗内识别最可能获益的患者。
  • 不适用人群:原文未提及。
  • 常见陷阱:P-TEG预测大量输血AUC 0.686判别力有限;高纤溶仅在rTEG LY30 7.6%阈值时相关,3%阈值不相关,解读需注意阈值依赖性。

指南或共识出处

  • 原文未提及具体指南或共识名称;研究发表于J Trauma Acute Care Surg。

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

BACKGROUND: Trauma patients with hyperfibrinolysis and depletion of fibrinolytic inhibitors (DFIs) measured by thrombelastography (TEG) gain clot strength with TXA, but TEG results take nearly an hour. We aimed to develop an assay, plasmin TEG (P-TEG), to more expeditiously stratify risk for massive transfusion (MT), mortality, and hyperfibrinolysis.

METHODS: Trauma patients (N = 148) were assessed using TEG assays without exogenous additives (rapid/native), with exogenous plasmin (P-TEG) or tissue plasminogen activator (tPA TEG). The plasmin dose used does not effect healthy-control clot lysis 30 minutes after maximum amplitude (LY30) but causes shortened reaction time (R time) relative to native TEG (P-TEG R time < native TEG R time considered P-TEG negative). If P-TEG R time is greater than or equal to native TEG R time, the patient was considered P-TEG positive. Each assay's ability to predict MT, mortality, and (risk for) hyperfibrinolysis was determined. χ and Mann-Whitney U tests were used to compare categorical and continuous variables, respectively. Results were reported as median ± interquartile range or n (%).

RESULTS: Plasmin TEG provided results faster than all other assays (4.7 ± 2.5-9.1 minutes), approximately 11-fold faster than rapid-TEG (rTEG) LY30 (54.2 ± 51.1-58.1 minutes; p < 0.001). Plasmin TEG-positive patients had greater than fourfold higher MT rate (30% vs. 7%; p = 0.0015) with an area under the receiver operating characteristic curve of 0.686 (p = 0.028), greater than fourfold higher 24-hour mortality (33.3% vs. 7.8%; p = 0.0177), greater than twofold higher 30-day mortality (35% vs. 16.4%; p = 0.0483), higher rates of DFI (55% vs. 18%; p < 0.001), and a trend toward elevated D-dimer (19.9 vs. 3.3 μg/mL; p = 0.14). Plasmin TEG was associated with hyperfibrinolysis on rTEG LY30 at the 7.6% threshold (p = 0.04) but not the 3% threshold (p = 0.40). Plasmin TEG performed best in relation to DFI, with a positive predictive value of 58% and negative predictive value of 81%. When combined with tPA TEG time to maximum amplitude, P-TEG outperformed rTEG LY30 for predicting MT (area under the receiver operating characteristic curve, 0.811 vs. 0.708).

CONCLUSION: Within 5 minutes, P-TEG can stratify patients at highest risk for MT, mortality, and risk for hyperfibrinolysis. In composite with tPA TEG time to maximum amplitude, P-TEG outperforms rTEG LY30 for predicting MT and does so four times faster (12.7 vs. 54.1 minutes). The rapid results of P-TEG may be useful for those who practice selective TXA administration to maximize TXA's time-dependent efficacy.

LEVEL OF EVIDENCE: Diagnostic test, level V.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Barrett CD, Moore HB, Vigneshwar N, et al. Plasmin thrombelastography rapidly identifies trauma patients at risk for massive transfusion, mortality, and hyperfibrinolysis: A diagnostic tool to resolve an international debate on tranexamic acid? J Trauma Acute Care Surg. 2020. PMID: 33230046. doi:10.1097/TA.0000000000002941

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。